Skip to main content
. 2020 Mar 20;10:5140. doi: 10.1038/s41598-020-60996-2

Table 4.

Association of PPARD and PPARG polymorphisms with glioma risk stratified by pathological classification and WHO grade.

Gene SNP Model Astrocytoma VS. Other glioma WHO grade
(III + IV VS. I + II)
OR(95%CI) P FDR- P OR(95%CI) P FDR- P
PPARD rs2016520 Allele 0.79(0.64–0.97) 0.025 0.224 0.97(0.73–1.28) 0.810 0.989
Co-dominant 0.60(0.34–1.05) 0.072 0.236 1.08(0.50–2.33) 0.844 0.989
0.80(0.61–1.05) 0.103 0.254 0.98(0.68–1.41) 0.923 0.992
Dominant 0.77(0.60–1.00) 0.048 0.224 0.99(0.70–1.41) 0.973 0.992
Recessive 0.66(0.38–1.14) 0.135 0.315 1.09(0.51–2.32) 0.826 0.989
Additive 0.79(0.64–0.97) 0.027 0.224 1.01(0.76–1.35) 0.956 0.992
PPARD rs67056409 Allele 0.80(0.65–0.98) 0.033 0.224 0.93(0.70–1.22) 0.598 0.989
Co-dominant 0.58(0.34–1.01) 0.054 0.227 0.80(0.36–1.77) 0.584 0.989
0.84(0.64–1.10) 0.198 0.362 1.03(0.72–1.48) 0.863 0.989
Dominant 0.80(0.62–1.03) 0.089 0.239 1.00(0.71–1.42) 0.992 0.992
Recessive 0.63(0.37–1.08) 0.091 0.239 0.79(0.36–1.72) 0.554 0.989
Additive 0.80(0.65–0.99) 0.039 0.224 0.97(0.73–1.29) 0.828 0.989
PPARD rs1053049 Allele 0.76(0.61–0.93) 0.009 0.224 0.92(0.69–1.23) 0.581 0.989
Co-dominant 0.56(0.32–0.98) 0.043 0.224 0.87(0.39–1.95) 0.744 0.989
0.77(0.59–1.02) 0.064 0.236 0.97(0.67–1.40) 0.871 0.989
Dominant 0.74(0.57–0.96) 0.024 0.224 0.96(0.67–1.36) 0.810 0.989
Recessive 0.62(0.36–1.08) 0.091 0.239 0.89(0.40–1.95) 0.762 0.989
Additive 0.76(0.62–0.94) 0.012 0.224 0.95(0.71–1.28) 0.754 0.989
PPARD rs2206030 Allele 1.09(0.91–1.31) 0.342 0.497 1.08(0.85–1.38) 0.510 0.989
Co-dominant 1.18(0.82–1.70) 0.376 0.497 1.14(0.69–1.88) 0.615 0.989
1.09(0.81–1.48) 0.572 0.632 1.38(0.91–2.10) 0.131 0.523
Dominant 1.12(0.84–1.49) 0.447 0.539 1.30(0.88–1.94) 0.192 0.620
Recessive 1.12(0.82–1.52) 0.489 0.555 0.92(0.61–1.39) 0.684 0.989
Additive 1.09(0.91–1.30) 0.372 0.497 1.08(0.84–1.38) 0.560 0.989
PPARG rs2920503 Allele 0.91(0.75–1.12) 0.379 0.497 1.27(0.98–1.64) 0.074 0.499
Co-dominant 0.92(0.57–1.49) 0.744 0.801 2.04(1.13–3.68) 0.018 0.378
0.85(0.65–1.11) 0.235 0.386 1.02(0.70–1.47) 0.933 0.992
Dominant 0.86(0.67–1.11) 0.255 0.397 1.17(0.83–1.65) 0.377 0.989
Recessive 0.99(0.63–1.58) 0.982 0.982 2.03(1.15–3.57) 0.014 0.378
Additive 0.91(0.75–1.12) 0.370 0.497 1.27(0.98–1.64) 0.074 0.499
PPARG rs4073770 Allele 1.02(0.85–1.24) 0.818 0.838 0.80(0.62–1.03) 0.083 0.499
Co-dominant 0.86(0.56–1.31) 0.480 0.555 0.70(0.38–1.27) 0.240 0.672
1.28(0.98–1.69) 0.073 0.236 0.73(0.51–1.06) 0.095 0.499
Dominant 1.18(0.91–1.53) 0.211 0.369 0.73(0.51–1.03) 0.071 0.499
Recessive 0.76(0.51–1.13) 0.170 0.340 0.82(0.46–1.45) 0.489 0.989
Additive 1.03(0.85–1.24) 0.799 0.838 0.80(0.61–1.04) 0.092 0.499
PPARG rs1151988 Allele 0.83(0.64–1.08) 0.160 0.340 1.25(0.88–1.78) 0.209 0.627
Co-dominant 0.62(0.21–1.88) 0.403 0.513 1.54(0.34–7.05) 0.580 0.989
0.84(0.62–1.13) 0.239 0.386 1.34(0.90–2.00) 0.154 0.539
Dominant 0.82(0.61–1.10) 0.191 0.362 1.35(0.91–2.00) 0.137 0.523
Recessive 0.65(0.22–1.97) 0.449 0.539 1.43(0.31–6.52) 0.646 0.989
Additive 0.83(0.63–1.08) 0.164 0.340 1.32(0.92–1.90) 0.137 0.523

SNP, single nucleotide polymorphism; MAF, minor allele frequency; HWE, Hardy-Weinberg equilibrium; OR, odds ratio; CI, confidence interval; FDR, false discovery rate.

Bold values indicate statistical significance (P < 0.05).